Pathogenesis of normal-tissue side-effects

Basic Clinical Radiobiology, Fourth Edition

Volumn , Issue , 2009, Pages 169-190

  Dörr, Wolfgang ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136441817     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15450-16     Document Type: Chapter

References (33)

1. Bentzen SM (2006). Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6: 702-13.
2. Bentzen SM, Turesson I, Thames HD (1990). Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy:a graded-response analysis. Radiother Oncol 18:95-106.
3. Bentzen SM, Saunders MI, Dische S, Bond SJ (2001). Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60:123-35.
4. Dittmann K, Mayer C, Rodemann HP (2005). Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol 76: 157-61.
5. Dörr W (1997). Three As of repopulation during fractionated irradiation of squamous epithelia:asymmetry loss, acceleration of stem-cell divisions and abortive divisions. Int J Radiat Biol 72:635-43.
6. Dörr W, Hendry JH (2001). Consequential late effects in normal tissues. Radiother Oncol 61: 223-31.
7. Dörr W, Herrmann T (2003). Pathogenetic mechanisms of lung fibrosis. In: Nieder C, Milas L, Ang KK (eds) Biological modification of radiation response. Berlin:Springer, 29-36.
8. Dörr W, Kummermehr J (1991). Proliferation kinetics of mouse tongue epithelium under normal conditions and following single dose irradiation. Virchows Arch B Cell Pathol Incl Mol Pathol 60: 287-94.
9. Dörr W, Bertmann S, Herrmann T (2005a). Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 181: 567-73.
10. Dörr W, Herrmann T, Riesenbeck D (eds) (2005b). Prävention und therapie von nebenwirkungen in der strahlentherapie. Bremen: UNI-MED Science.
11. Fajardo LF, Berthrong M, Anderson RE (2001). Radiation pathology. New York: Oxford University Press.
12. Hakenjos L, Bamberg M, Rodemann HP (2000). TGFbeta1- mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 76: 503-9.
13. Herrmann T, Baumann M, Dörr W (2006). Klinische strahlenbiologie - kurz und bündig, 4th edn. Munich:Elsevier.
14. Horiot JC, Bontemps P, van den Bogaert W et al. (2006). Accelerated Fractionation (AF) compared to Conventional Fractionation (CF) improves locoregional control in the radio therapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44: 111-21.
15. Jaal J (2006). Radiation effects in the urinary bladder (mouse): histopathologic features and modification by recombinant human keratinocyte growth factor. Thesis, Technische Universität Dresden.
16. Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T (2001). Quantification of late complications after radiation therapy. Radiother Oncol 61: 233-46.
17. Potten CS, Hendry JH (eds) (1983). Cytotoxic insults to tissues: effects on cell lineages. Edinburgh:Churchill-Livingstone.
18. Rodemann HP, Bamberg M (1995). Cellular basis of radiation-induced fibrosis. Radiother Oncol 35: 83-90.
19. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995). A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33: 99-109.
20. Schultz-Hector S (1992). Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 61:149-60.
21. Sonis ST (2004). A biological approach to mucositis. J Support Oncol 2: 21-32.
22. Turesson I (1990). Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19:1569-74
23. van der Kogel AJ (1991). Central nervous system radiation injury in small animal models. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. New York: Raven Press, 91-111
24. van der Schueren E, van den Bogaert W, Vanuytsel L, van Limbergen E (1990). Radiotherapy by multiple fractions per day (MFD) in head and neck cancer:acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 19: 301-11.
25. Withers HR, Elkind MM (1970). Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol 17: 261-7.
26. Withers HR, Taylor JM, Maciejewski B (1988). Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 14: 751-9.
27. Bentzen SM, Dörr W, Anscher MS et al. (2003). Normal tissue effects: reporting and analysis. Semin Radiat Oncol 13: 189-202.
28. Brown JM, Mehta MP, Nieder C (eds) (2006). Multimodal concepts for integration of cytotoxic drugs and radiation therapy. Berlin: Springer.
29. Dörr W (ed.) (2001). Growth factors in the pathogenesis of radiation effects in normal tissues. Munich: Urban and Vogel.
30. Dörr W (2006). Skin and other reactions to radiotherapy - clinical presentation and radiobiology of skin reactions. Front Radiat Ther Oncol 39: 96-101.
31. Grötz KA, Riesenbeck D, Brahm R et al. (2001). Chronic radiation effects on dental hard tissue (radiation caries). Classification and therapeutic strategies. Strahlenther Onkol 177: 96-104.
32. National Cancer Institute, Washington DC, USA (w2006). Common terminology criteria for adverse events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf
33. Pavy JJ, Denekamp J, Letschert J et al. (1995). EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35: 11-5.